Disease Overview

Breast cancer is a malignant tumor originating in the breast tissue, classified into non-invasive and invasive types, further categorized into hormone receptor-positive, HER2-positive, and triple-negative subtypes. It is the most common cancer among women globally, with an estimated 2.3 million new cases diagnosed each year worldwide.

China accounts for approximately 17% of global breast cancer cases, with over 420,000 new cases annually.

Risk Factors

• Female gender and increasing age
• Family history and genetic mutations (BRCA1/BRCA2)
• Hormone replacement therapy
• Obesity and sedentary lifestyle
• Alcohol consumption
• Early menarche or late menopause

Symptoms

• A lump or thickening in the breast or underarm
• Change in breast size, shape, or appearance
• Dimpling, puckering, or skin changes
• Nipple inversion or discharge
• Redness or scaling of the nipple or breast skin

Core Treatment Capabilities at Fosun Health

1. Breast Preservation by Design — Oncoplastic Surgery & Organ-Sparing Ablation

Two pathways designed around a single principle—the cancer goes; the breast stays. Pathway A: Image-guided precision ablation (RFA, MWA, cryoablation) for selected patients with small, localized tumors. Pathway B: Oncoplastic breast-conserving surgery with immediate reshaping for optimal aesthetic outcome. For mastectomy cases, nipple-sparing mastectomy with immediate reconstruction.

2. Recurrence Without Re-Operation — CyberKnife Radiosurgery

CyberKnife M6 delivers 0.1mm sub-millimeter stereotactic radiosurgery for postoperative chest wall recurrences, lymph node relapses, or bone/lung oligometastases. Completely non-invasive—1 to 5 outpatient sessions, no interruption to systemic therapy.

3. Systemic Therapy Access & Affordability

For HER2-positive disease: trastuzumab deruxtecan (T-DXd) and HER2-directed bispecific antibodies. Hormone receptor-positive: CDK4/6 inhibitors + endocrine therapy. Triple-negative: PD-1/PD-L1 immunotherapy combinations. Comprehensive costs at 30%–50% of Western prices.

4. Lymphedema Care & Treatment Tolerance

Integrative TCM program with acupuncture and herbal protocols for lymphedema prevention, chemotherapy toxicity reduction, and immune support—keeping you strong enough to complete every planned cycle.

Multidisciplinary Approach

Every breast cancer case is reviewed by a panel comprising breast surgery, medical oncology, radiation oncology, plastic/reconstructive surgery, radiology, and pathology specialists. The MDT convenes within 48 hours, delivering a consensus plan optimized for your cancer biology, your priorities, and your life circumstances.